{
  "docId": "019de077-5087-71ae-b0e8-0abfd1317859",
  "docSlug": "b6fff97596ca7cba1b2ee8405a1dc7cd",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 38 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 38,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": "Slide 16 of a presentation deck. Includes a legend for established SoC vs ongoing trials.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-5087-71ae-b0e8-0abfd1317859/16",
  "deckHref": "/decks/019de077-5087-71ae-b0e8-0abfd1317859",
  "deckJsonHref": "/decks/019de077-5087-71ae-b0e8-0abfd1317859.json",
  "deckAnchorHref": "/decks/019de077-5087-71ae-b0e8-0abfd1317859#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.35,
        "y": 0.82
      },
      "kind": "callout",
      "text": "Dato-DXd | FDA submission EGFRm later line NSCLC | TROPION-Lung01 withdrawn",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e312977-3222-4a9b-b135-19f37a83c5ac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.3,
        "x": 0.05,
        "y": 0.38
      },
      "kind": "chart",
      "text": "Early-stage, 1st-line, 2nd-line+ clinical trial progression",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "31c1be0b-2bc1-47f3-9962-73cd887af1b3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.05,
        "y": 0.275
      },
      "kind": "list",
      "text": "Tagrisso established backbone treatment for EGFRm NSCLC",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c6e5835e-8f9a-4823-8acf-d15253a5fff0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.35,
        "y": 0.29
      },
      "kind": "paragraph",
      "text": "Novel combinations extend Tagrisso use across multiple lines of therapy",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cb2b4727-8230-4a33-a857-c0648a40018a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.03,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1. Defined as IHC90+ and/or FISH10+. Collaboration partners: Daiichi Sankyo (Dato-DXd); Hutchmed (Orpathys).",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "43bd94eb-a60d-414e-820e-ccfef767f00f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.6,
        "x": 0.35,
        "y": 0.35
      },
      "kind": "table",
      "text": "Tagrisso + savolitinib and Tagrisso + Dato-DXd clinical trial status",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "372ee0b2-514d-4eee-b0a5-6f0fd8ebaf47",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.84,
        "x": 0.03,
        "y": 0.13
      },
      "kind": "title",
      "text": "Reinforcing leadership in EGFRm NSCLC with novel treatment approaches",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "13e1ddfd-7dd1-4fa3-8eb0-ac82cd52c819",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.48,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Oncology – R&D highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71ff9c85-e91f-4e8a-aa2c-d6b622b651af",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "NxN matrix",
      "slug": "matrix-nxn",
      "agent": null,
      "layer": "slide",
      "matchId": "458635cf-1e60-46a6-889a-7f6c4c8a3944",
      "evidence": "diagram/matrix-nxn: Pipeline matrix showing Cardiovascular, Renal, and Metabolism areas across monotherapy and novel combinations.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "6e58b9f5-496d-4ee6-97da-ead596507c53",
      "evidence": "Categorization of clinical trials by line of therapy",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 20,
      "from": 15,
      "name": "Voice Of Customer",
      "slug": "51-voice-of-customer",
      "bestFor": "Product strategy, customer experience, market research",
      "matchId": "801eb17b-6c5b-4193-b615-ad2a5662f696",
      "evidence": "The presentation highlights the company's focus on customer needs, particularly in Oncology and BioPharmaceuticals.",
      "position": 1,
      "objective": "What are the needs and concerns of AstraZeneca's customers?",
      "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
      "confidence": 0.6,
      "description": "Let customer quotes and feedback drive the narrative and validate the insight"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}